Lv11
68 积分 2025-01-12 加入
Molecular, clinical, and therapeutic determinants of outcome in NPM1 -mutated AML
12分钟前
待确认
Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single‐centre experience
2个月前
已完结
Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): An evaluation of melatonin effects
2个月前
已完结
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
6个月前
已完结
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
6个月前
已完结
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
1年前
已完结